comprehensive -WSS

comprehensive

author：fashion 2025-09-30 21:04:32 - browse：3845

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Insmed lung disease drug hits target in key Phase 3 trial

WSS

For AI in health care standards, federal regulators join with industry group

Families look for replacement for GSK asthma drug Flovent

Harvard's David Sinclair gets blowback over aging

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Immune cells and nerve overgrowth may explain recurring UTI pain

Harvard's David Sinclair gets blowback over aging

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Wikipedia

What does generative AI mean for health care? We asked experts

Lack of health data on LGBTQ+ people has serious consequences

Cancer drug shortages should be causing more outrage

Latest bird flu infection made farmworker sicker than earlier cases

Hollywood unions extend contract negotiations for actors

Akili, maker of video game for ADHD, to be acquired for 34 million

Malaria cases in Florida and Texas: Here’s what you need to know

State of the Union pitch: Bigger Medicare drug price negotiations

Drug repurposing or repositioning? The language matters

Adam's Biotech Scorecard: Do Sarepta's exon

knowledge

First Opinion Podcast: What happens when kids become caregivers?

Average age of first period drops to 11.9 years, study shows

Stigma and the return of syphilis

What will save rural psychiatry services? Higher Medicaid payments

Latest bird flu infection made farmworker sicker than earlier cases

iTeos Therapeutics debuts first data on TIGIT

explore

focus

leisure time

focus